Last news
Huawei's MoM-based Multi-Agent Collaboration System Empowers Core Networks' Transitioning to L4 High Stability

Huawei's MoM-based Multi-Agent Collaboration System Empowers Core Networks' Transitioning to L4 High Stability

SHENZHEN, China, Dec. 22, 2025 /PRNewswire/ -- In an increasingly digital era, modern life and economic activities heavily rely on networks. Network stability directly impacts public 'digital well-being' and 'sense of social participation.' As the...

Menarini Silicon Biosystems announces PACE trial biomarker analysis results confirming clinical utility of CELLSEARCH® CTC enumeration to guide treatment decisions in a specific metastatic breast cancer subtype

Menarini Silicon Biosystems announces PACE trial biomarker analysis results confirming clinical utility of CELLSEARCH® CTC enumeration to guide treatment decisions in a specific metastatic breast cancer subtype

The secondary analysis of the PACE trial highlights the value of counting Circulating Tumor Cells (CTCs) in the blood to help guide treatment escalation or de-escalation in patients with hormone receptor-positive (HR+), HER2-negative (HER2-)...

Beko Secures €100 Million Sustainability-Linked Loan from IFC to Drive Global Innovation and Net-Zero Transformation

Beko Secures €100 Million Sustainability-Linked Loan from IFC to Drive Global Innovation and Net-Zero Transformation

Beko has secured its first sustainability-linked loan to expand renewable energy capacity, strengthen earthquake resilience, and promote next-generation eco-efficient appliances and diversity, with sustainability targets tied to emission reduction...

Guardant Health Japan receives regulatory approval of Guardant360® CDx liquid biopsy as companion diagnostic for imlunestrant in metastatic or recurrent breast cancer previously treated with endocrine therapy

Guardant Health Japan receives regulatory approval of Guardant360® CDx liquid biopsy as companion diagnostic for imlunestrant in metastatic or recurrent breast cancer previously treated with endocrine therapy

Guardant360® CDx is the first companion diagnostic to be approved in Japan to identify ESR1 mutations in patients with hormone receptor-positive, HER2-negative breast cancer for treatment with imlunestrant TOKYO, Dec. 22, 2025 /PRNewswire/ --...

Fijian and Chinese Scholars Gather to Discuss Bilateral Friendship and the Outlook for APEC 2026

Fijian and Chinese Scholars Gather to Discuss Bilateral Friendship and the Outlook for APEC 2026

SHENZHEN, China, Dec. 22, 2025 /PRNewswire/ -- Shenzhen Media Group's "Telling China's Story: The 'Circle of Friends' of the Global Development Initiative" program has brought the "Gather in Shenzhen" Salon Series to Suva, Fiji, at the China...

SKF achieves prestigious CDP 'A' Score for Environmental Leadership

SKF achieves prestigious CDP 'A' Score for Environmental Leadership

GOTHENBURG, Sweden, Dec. 22, 2025 /PRNewswire/ -- For the third consecutive year SKF has earned an 'A' score in the category Climate Change from CDP, the global non-profit leading environmental disclosure. In 2025 nearly 20,000 companies were scored...

International Forum "Problem-Solving City: Hong Kong as a Disputes Resolver"

International Forum "Problem-Solving City: Hong Kong as a Disputes Resolver"

HONG KONG, Dec. 22, 2025 /PRNewswire/ -- On December 19, 2025, Hong Kong hosted the forum "Problem-Solving City: Hong Kong as a Disputes Resolver", co-organized by Friday Culture Limited, Hong Kong Coalition, and the AALCO Hong Kong Regional...

OK Biotech Recognized at International Innovation Awards (IIA) 2025 for OTC Hearing Aid Innovation

OK Biotech Recognized at International Innovation Awards (IIA) 2025 for OTC Hearing Aid Innovation

SHANGHAI, Dec. 22, 2025 /PRNewswire/ -- OK Biotech Co., Ltd. has been honoured at the International Innovation Awards (IIA) 2025, organized by Enterprise Asia, for its development of the OKB OTC Hearing Aid, a device designed to improve comfort and...

1 ... 21 22 23 24 25 26 27 28 29 ... 3435
menu
menu